Kevin Lee

Kevin Lee (chief executive) discloses dealings in BICYCLE THERAPEUTICS plc to SEC (Form 4). Between 3 May 2021 and 5 October 2026, the trades on record add up to 29 filings.

On the market, this insider has only sold: 17 sales, €860k in total. The rest of the record consists of 5 share grants and 7 option exercises. So far in 2026, the count stands at no purchases and 6 sales.

On 6 October 2026 came the latest disclosure, an open-market sale for €19k in BICYCLE THERAPEUTICS plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.